Cresset BioMolecular Discovery Ltd

0 products

Cresset was formed in 2002 using the basic research of our founder Dr Andy Vinter to introduce a new virtual screening technology. Over the last decade our technology has been widely adopted throughout the drug discovery and agrochemical industries. At the same time our product suite has grown to encompass desktop and enterprise level solutions. Currently our customers include many of the top 20 pharamaceutical companies, large and small biotechs across the USA, Europe and Japan, agrochemical companies as well as top academics. Our technology is based on the scientific developments of XEDs and Fields made by Dr Andy Vinter whilst at Cambridge University and working as a consultant to the pharmaceutical industry. These have been developed by Cresset BMD Ltd over the last 8 years. Cresset’s in-house expertise encompasses medicinal, synthetic, combinatorial, and physical chemistry combined with in-depth computational skills in molecular modelling, QSAR and programming. We are loca